Vivos Therapeutics, Inc. (VVOS)
0.6755
+0.01
(+0.82%)
USD |
NASDAQ |
May 29, 16:00
0.70
+0.02
(+3.63%)
After-Hours: 20:00
Vivos Therapeutics Profit Margin (Quarterly) : -150.8% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Hinge Health, Inc. | 18.66% |
| Exlites Holdings International, Inc. | -104.8% |
| Xcelerate, Inc. | -- |
| Abbott Laboratories | 9.65% |
| AngioDynamics, Inc. | -10.31% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.44K% |
| Return on Assets | -111.0% |
| Return on Invested Capital | -209.5% |
| Gross Profit Margin (Quarterly) | 50.67% |
| Operating Margin (Quarterly) | -128.7% |
| Return on Net Operating Assets | -128.1% |